These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 2491952

  • 21. Infusional carboplatin. Phase I studies of 5-day and 14-day infusions.
    Lokich J, Anderson N, Bern M, Zipli T, Gonsalves L, Moore C.
    Cancer; 1991 Jul 01; 68(1):68-71. PubMed ID: 2049755
    [Abstract] [Full Text] [Related]

  • 22. Double-conditioning regimens consisting of thiotepa, melphalan and busulfan with stem cell rescue for the treatment of pediatric solid tumors.
    Hara J, Osugi Y, Ohta H, Matsuda Y, Nakanishi K, Takai K, Fujisaki H, Tokimasa S, Fukuzawa M, Okada A, Okada S.
    Bone Marrow Transplant; 1998 Jul 01; 22(1):7-12. PubMed ID: 9678789
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Phase I study of high-dose busulfan, melphalan and thiotepa with autologous stem cell support in patients with refractory malignancies.
    Weaver CH, Bensinger WI, Appelbaum FR, Lilleby K, Sandmaier B, Brunvand M, Rowley S, Petersdorf S, Rivkin S, Gooley T.
    Bone Marrow Transplant; 1994 Nov 01; 14(5):813-9. PubMed ID: 7889015
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Phase I study of topotecan administered as a 21-day continous infusion in children with recurrent solid tumors: a report from the Children's Cancer Group.
    Frangoul H, Ames MM, Mosher RB, Reid JM, Krailo MD, Seibel NL, Shaw DW, Steinherz PG, Whitlock JA, Holcenberg JS.
    Clin Cancer Res; 1999 Dec 01; 5(12):3956-62. PubMed ID: 10632325
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Repetitive cycles of cyclophosphamide, thiotepa, and carboplatin intensification with peripheral-blood progenitor cells and filgrastim in advanced breast cancer patients.
    Shapiro CL, Ayash L, Webb IJ, Gelman R, Keating J, Williams L, Demetri G, Clark P, Elias A, Duggan D, Hayes D, Hurd D, Henderson IC.
    J Clin Oncol; 1997 Feb 01; 15(2):674-83. PubMed ID: 9053493
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Pharmacokinetics of cyclophosphamide and thiotepa in a conventional fractionated high-dose regimen compared with a novel simplified unfractionated regimen.
    Ekhart C, Rodenhuis S, Beijnen JH, Huitema AD.
    Ther Drug Monit; 2009 Feb 01; 31(1):95-103. PubMed ID: 19155964
    [Abstract] [Full Text] [Related]

  • 35. Phase III study of bolus versus infusion fluorouracil with or without cisplatin in advanced colorectal cancer.
    Hansen RM, Ryan L, Anderson T, Krzywda B, Quebbeman E, Benson A, Haller DG, Tormey DC.
    J Natl Cancer Inst; 1996 May 15; 88(10):668-74. PubMed ID: 8627643
    [Abstract] [Full Text] [Related]

  • 36. Phase I clinical and pharmacokinetic study of thiotepa administered intraperitoneally in patients with advanced malignancies.
    Wadler S, Egorin MJ, Zuhowski EG, Tortorello L, Salva K, Runowicz CD, Wiernik PH.
    J Clin Oncol; 1989 Jan 15; 7(1):132-9. PubMed ID: 2491884
    [Abstract] [Full Text] [Related]

  • 37. Prolonged infusion of hexamethylene bisacetamide: a phase I and pharmacological study.
    Rowinsky EK, Ettinger DS, McGuire WP, Noe DA, Grochow LB, Donehower RC.
    Cancer Res; 1987 Nov 01; 47(21):5788-95. PubMed ID: 3664482
    [Abstract] [Full Text] [Related]

  • 38. Clinical pharmacologic effects of thymidine plus 5-FU.
    Ohnuma T, Roboz J, Waxman S, Mandel E, Martin DS, Holland JF.
    Cancer Treat Rep; 1980 Nov 01; 64(12):1169-77. PubMed ID: 7471111
    [Abstract] [Full Text] [Related]

  • 39. Phase I evaluation of therapy with four schedules of 5-fluorouracil by continuous infusion combined with recombinant interferon alpha.
    Greenblatt MS, Mangalik A, Ferguson J, Elias L.
    Clin Cancer Res; 1995 Jun 01; 1(6):615-20. PubMed ID: 9816023
    [Abstract] [Full Text] [Related]

  • 40. Phase I trial of ICRF-187 by 48-hour continuous infusion.
    Koeller JM, Earhart RH, Davis HL.
    Cancer Treat Rep; 1981 Jun 01; 65(5-6):459-63. PubMed ID: 6786740
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.